Holen Sie sich die Stockscreener-App
3.06
0.33%
0.01
Vorhandelsmarkt:
2.95
-0.11
-3.59%
Schlusskurs vom Vortag:
$3.05
Offen:
$3.01
24-Stunden-Volumen:
811.25K
Relative Volume:
0.75
Marktkapitalisierung:
$144.14M
Einnahmen:
$138.90M
Nettoeinkommen (Verlust:
$-107.15M
KGV:
-1.2127
EPS:
-2.5232
Netto-Cashflow:
$-79.85M
1W Leistung:
+13.75%
1M Leistung:
+0.33%
6M Leistung:
-57.85%
1J Leistung:
-41.55%
1-Tages-Spanne:
$2.95
$3.125
1-Wochen-Bereich:
$2.585
$3.125
52-Wochen-Spanne:
$2.395
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Firmenname
Quanterix Corp
Sektor
Branche
Telefon
617-301-9400
Adresse
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
3.06 | 143.67M | 138.90M | -107.15M | -79.85M | -2.5232 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-09-25 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-15 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-08-09 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Hochstufung | Goldman | Sell → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Sell |
Alle ansehen
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
QTRX Technical Analysis & Stock Price Forecast - Intellectia AI
Quanterix Corporation Appoints Anthony Catalano as Chief Operations Officer – Employment Agreement Details and Corporate Information - Minichart
Quanterix names Anthony Catalano COO; Michael Miller becomes Chief Technology and Products Officer - TradingView
New Quanterix COO Anthony Catalano gets 141,330 restricted stock units - Stock Titan
Quanterix targets $169M-$174M 2026 revenue while preparing HD-X IVD filing in 2027 - MSN
Quanterix (QTRX) CFO reports RSU vesting and tax-withholding share dispositions - Stock Titan
Quanterix (QTRX) CTO gains 1,558 shares from RSU vesting, 467 withheld for tax - Stock Titan
Quanterix Corp stock (US74876Y1001): Analyst price target raised while shares trade near lows - AD HOC NEWS
Portolan Capital, George McCabe report 6.25% stake in Quanterix (QTRX) - Stock Titan
Quanterix CFO Vandana Sriram to depart - MSN
Quanterix (NASDAQ: QTRX) — Ameriprise reports 3,542,374 shared votes - Stock Titan
QTRX Technical Analysis | Trend, Signals & Chart Patterns | QUANTERIX CORP (NASDAQ:QTRX) - ChartMill
Quanterix stock (US74876Y1001): Biotech diagnostics firm faces headwinds amid guidance revision - AD HOC NEWS
AMERIPRISE FINANCIAL INC Significantly Reduces Stake in Quanteri - GuruFocus
Quanterix (QTRX) Announces CFO Departure and Transition Plans - GuruFocus
Quanterix CFO Vandana Sriram to depart in June - Investing.com
Quanterix CFO Michael J. Doyle to Depart on July 3, 2026; Search for Successor Begins - geneonline.com
Quanterix (QTRX) CFO Vandana Sriram to depart in June 2026 after planned transition - Stock Titan
Quanterix finance chief to depart after June 15 handover - Stock Titan
TradingKey - TradingKey
MSN Money - MSN
Quanterix (NASDAQ:QTRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix Corporation 2026 Q1 Financials: Akoya Acquisition, Revenue Performance & Forward-Looking Statements - Minichart
QTRX Maintained by TD Cowen -- Price Target Lowered to $4.00 - GuruFocus
Q1 2026 Quanterix Corp Earnings Call Transcript - GuruFocus
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses By Investing.com - Investing.com India
Quanterix CEO Everett Cunningham Highlights Market Leadership in Earnings Call - HarianBasis.co
Ameriprise Financial (NASDAQ: QTRX) reports 990,224 shares, 2.1% stake - Stock Titan
Quanterix Q1 Earnings Call Highlights - Yahoo Finance
Quanterix Q1 2026 slides: $85M synergies offset organic decline - Investing.com
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses - Investing.com
Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss - ChartMill
Quanterix (NASDAQ: QTRX) grows revenue 20% but books $19.3M impairment - Stock Titan
QUANTERIX ($QTRX) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Quanterix (NASDAQ: QTRX) grows Q1 revenue 20% and keeps 2026 outlook - Stock Titan
Quanterix keeps 2026 outlook, eyes FDA decision on Alzheimer’s test - Stock Titan
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Quanterix Corp expected to post a loss of 54 cents a shareEarnings Preview - TradingView
How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset - Yahoo Finance
Quanterix (QTRX) COO logs RSU conversion and small tax share disposal - Stock Titan
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Finanzdaten der Quanterix Corp-Aktie (QTRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):